{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "As a single agent, for the treatment of adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma (ASPS)",
    "geneContextQualifier": "--",
    "objectTherapeutic": "Atezolizumab [Tecentriq]"
}